Glargine basal-bolus insulin regimen versus insulin pump therapy: Comparison of glycemic control

Journal of Pediatric Endocrinology and Metabolism

Volumn 24, Issue 5-6, 2011, Pages 369-371

  Starkman, Harold ^a   Frydman, Emily ^a   Bustami, Rami ^a  

^a Goryeb Children's Hospital   (United States)

Author keywords

basal bolus insulin regimen; continuous subcutaneous insulin infusion; insulin glargine; insulin pump; intensive insulin therapy; type 1 diabetes

Indexed keywords

GLARGINE BASAL BOLUS INSULIN REGIMEN; HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; INSULIN GLARGINE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG EFFICACY; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MALE; MEDICAL RECORD REVIEW; PEDIATRICS; PRESCHOOL CHILD; SCHOOL CHILD; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INSULIN; INSULIN INFUSION SYSTEMS; MALE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 79959402463     PISSN: 0334018X     EISSN: 0334018X     Source Type: Journal    
DOI: 10.1515/JPEM.2011.018     Document Type: Article

References (14)

1. Lepore G, Dodesini AR, Nosari I, Trevisan R. Effect of continuous subcutaneous insulin infusion vs. multiple daily insulin injection with glargine as basal insulin: an open parallel long-term study. Diabetes Nutr Metab 2004;17:84-9. (Pubitemid 38744626)
2. Garg, S, Walker A, Hoff H, D'Souza A, Gottlieb P, Chase H. Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump. Diabetes Technol Ther 2004;6:9-15. (Pubitemid 38233740)
3. Alemazadeh, R, Palma-Sisto P, Holzum M, Parton E, Kichler J. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus. Diabetes Technol Ther 2007;9:339-47. (Pubitemid 47340083)
4. Garcia-Garcia, E, Galera R, Aguilera P, Cara G, Bonillo A. Long-term use of continuous subcutaneous insulin infusion compared with multiple daily injection of glargine in pediatric patients. J Pediatr Endocrinol Metab 2007;20:37-40. (Pubitemid 46863536)
5. Bruttomesso, D, Crazzolar D, Maran A, Costa S, Dal Pos M, et al. In type 1 diabetic patients with good glycaemic control blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabetes Med 2008;25:326-32. (Pubitemid 351322703)
6. Bolli, G, Kerr D, Thomas R, Torlone E, Sola-Gazagnes A, et al. Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes. Diabetes Care 2009;32:1170-6.
7. Schiaffini R, Ciampalini P, Spera S, Cappa M, Crino A. An observational study comparing continuous subcutaneous insulin (CSII) and insulin glargine in children with type 1 diabetes. Diabetes Metab Res Rev 2005;21:346-52.
8. Doyle E, Winzimer S, Steffen A, Ahern J, Vincent M, et al. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injection using insulin glargine. Diabetes Care 2004; 27:1554-8. (Pubitemid 38857425)
9. Pickup J, Renard E. Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes. Diabetes Care 2008;31(Suppl 2):S140-5.
10. Bin-Abbas BS, Al-Fares A, Sakati NA, Al-Ashwal AA. Comparison of insulin pump and multiple daily injection regimens in type 1 diabetes patients. Curr Pediatr Res 2006;10:37-9. (Pubitemid 44409866)
11. Schiaffini R, Patera P, Bizzarri P, Caimpalini P, Cappa M. Basal insulin supplementation in type 1 diabetic children: a long-term comparative observational study between continuous subcutaneous insulin infusion and glargine insulin. J Endocrinol Investig 2007;30:572-7. (Pubitemid 47577810)
12. Alemzadeh R, Ellis J, Holzum M, Parton E, Wyatt D. Beneficial effects of continuous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes. Pediatrics 2004;114:e91-5.
13. Hirsch I, Bruce B, Garg S, Lane WS, Sussman A, et al. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetes patients previously treated with CSII. Diabetes Care 2005;28:533-8. (Pubitemid 40315309)
14. Simon B, Treat V, Marco C, Rosenberg D, Joseph J, et al. A comparison of glycemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS. Int J Clin Pract 2008;62:1858-63.